By Alex Langton | 27 February 2024
Mike Caine and I have a financial interest in OptiBiotix Health.
So will Father Grumps soon, i suspect.
Navigating the intricate landscape of innovative, disruptive technology investments is akin to an odyssey through a dense jungle, where the protection of trade secrets is as fierce as a lion safeguarding its progeny. Yet, this journey, brimming with foreseen challenges and serendipitous hurdles, is undeniably exhilarating for the steadfast investor. The saga surrounding SweetBiotix® unfolds like a page-turner, reminiscent of a Stephen King thriller, leaving us on tenterhooks for the denouement. And lo, the horizon gleams with the prospect of resolution, much to the delight of enthusiasts and sceptics alike, including the notable sceptic, our very own Mike Caine, who, in a surprising turn of events, has bolstered his stake in OptiBiotix Health. The tale is so compelling that even the most cautious are tempted to join the fray.